Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07723066
Biomarker Discovery for Suicide Precision Circuit Therapeutics
Sponsor: Massachusetts General Hospital
View on ClinicalTrials.gov
Summary
This is a prospective observational biomarker study assessing changes in clinical, behavioral, neuroimaging, and neurophysiological measurer following ketamine/esketamine or electroconvulsive therapy (ECT) in adults with suicidal thoughts or behaviors.
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
OBSERVATIONAL
Enrollment
60
Start Date
2026-07
Completion Date
2030-08-31
Last Updated
2026-07-23
Healthy Volunteers
No